Back to search

Article

Dapagliflozin vs. empagliflozin in patients with chronic heart failure: a single-center registry analysis

2024-08-26

Abstract excerpt

<h4>Purpose: </h4> To assess relative efficacy of dapagliflozin and empagliflozin in routinely treated chronic heart failure (CHF) patients. Methods. In this single-center registry analysis, prevalent and incident CHF patients with a wide range of left ventricular ejection fraction values started on dapagliflozin or empagliflozin in addition to other guideline-directed therapy were mutually balanced on a range of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a6dd9157-ee5d-5fbb-9870-0db77023fb6c
DOI
10.22541/au.172469758.84933755/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dapagliflozin vs. empagliflozin in patients with chronic heart failure: a single-center registry analysisDOI 10.22541/au.172469758.84933755/v1
Cardiovascular drugs approved for heart failure with reduced ejection fraction and/or post-myocardial infarction exert consistent effects in both populations: A meta-analysis and meta-regression of randomized controlled trialsSemantic proximity
Ventricular remodeling with dapagliflozin in elderly women with HFpEF--a single center prospective studySemantic proximity
Empagliflozin and Dapagliflozin in Improving Ejection Fraction: A Prospective Observational Comparison of Clinical Outcomes and Patient Reported Quality of LifeSemantic proximity
Cardiorenal Outcomes with Finerenone in Patients Post-Acute Myocardial Infarction: Insights from a Global Federated NetworkSemantic proximity
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudySemantic proximity
Long-term Effectiveness of PCSK9 Inhibitors versus Ezetimibe as Adjunctive Therapy to Statins in Patients with Atherosclerotic Cardiovascular Disease: A TriNetX Database AnalysisSemantic proximity
Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model.Semantic proximity
Evaluation of demographic, clinical characteristics, and the prescribing practice of guideline-directed medical therapy among chronic heart failure outpatients in multidisciplinary clinics in a large tertiary hospital: a retrospective audit of 1186 patients from 12 yearsSemantic proximity
Using Artificial Intelligence to Assess Treatment-Effect Heterogeneity in Pragmatic Cardiovascular Trials: Insights from TRANSFORM-HFSemantic proximity
Real-World Effectiveness of SGLT2 Inhibitors Across Heart Failure Phenotypes: A Meta-Analysis.Semantic proximity
Digoxin use and outcomes in contemporary heart failure: a propensity score-weighted real-world analysisSemantic proximity
Effect of SGLT-2 Inhibitors on Cardiovascular Outcomes Among Patients With Heart Failure and Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis of Randomized Controlled TrialsSemantic proximity
Select a neighboring publication to make it the new centre.